Medical Devices & Biotech
Tonkon Torp has supported the Northwest’s medical devices and biotech businesses since their earliest days. We’ve represented and advised public and private organizations of all sizes, as well as nonprofit institutions. Many of our clients have been instrumental to the growing presence of these industries in the Pacific Northwest. These include the Oregon Bioscience Incubator and the Oregon Translational Research and Development Institute (OTRADI).
We help our clients navigate the legal complexities of digital health, therapeutic and diagnostic matters. We are able to provide our clients with a full range of legal services including corporate governance, intellectual property and government relations.
We help our clients navigate the legal complexities of digital health, therapeutic and diagnostic matters. We are able to provide our clients with a full range of legal services including corporate governance, intellectual property and government relations.
1520876306-23731.jpg)
M&A and Bioscience Expertise Combine for Client Acquisition
The acquisition of Tonkon Torp client TomegaVax by San Francisco-based Vir Biotechnology marks a significant boom for Oregon’s growing role in the bioscience industry. Find details and more featured cases here.
Corporate Conversion and Financing for Circuitry Company
Advised client with the negotiation of a term sheet and the documentation of the conversion from an Oregon corporation into a Delaware corporation, as well as the offer, issuance and sale of Series A Preferred Stock to a venture capital fund.
4.23.2020
Trump Proclamation Suspends Entry of Immigrant Visa Applicants Into U.S. for 60 Days
On April 22, 2020, President Trump issued a Presidential Proclamation temporarily suspending entry into the United States of certain foreign nationals outside the United States seeking immigrant visas. The Proclamation has several exceptions, and…
Representative Matters
Corporate Conversion and Financing for Circuitry Company
Advised client with the negotiation of a term sheet and the documentation of the conversion from an Oregon corporation into a Delaware corporation, as well as the offer, issuance and sale of Series A Preferred Stock to a venture capital fund.